Fandom

VroniPlag Wiki

Mag/Fragment 016 27

< Mag

31.340Seiten in
diesem Wiki
Seite hinzufügen
Diskussion0 Share

Störung durch Adblocker erkannt!


Wikia ist eine gebührenfreie Seite, die sich durch Werbung finanziert. Benutzer, die Adblocker einsetzen, haben eine modifizierte Ansicht der Seite.

Wikia ist nicht verfügbar, wenn du weitere Modifikationen in dem Adblocker-Programm gemacht hast. Wenn du sie entfernst, dann wird die Seite ohne Probleme geladen.


Typus
Verschleierung
Bearbeiter
Hindemith
Gesichtet
Yes.png
Untersuchte Arbeit:
Seite: 16, Zeilen: 27-30
Quelle: Fehrenbach 2001
Seite(n): 34, Zeilen: l.col: 2-14
The surface-active agent was characterized in numerous biochemical studies of BAL material and is now known to be composed of ∼90% lipids (with ∼80-90% phospholipids) and of ∼10% proteins (Griese, 1999). Unlike most other lipid-rich components of cells and organs, the surfactant lipids are characterized by an [unusually high level of satured [sic] fatty acid chains, such as the predominant dipalmitoylphosphatidylcholines, which contribute substantially to the unique properties of pulmonary surfactant (van Golde et al., 1994).]

Griese M. Pulmonary surfactant in health and human lung diseases: state of the art. Eur Respir J. 1999 Jun; 13 (6): 1455-76. Review.

van Golde LMG, BatenburgJJ, Robertson B The pulmonary surfactant system. News in Physiol Sciences 1994, 9:13-20.

This surface-active agent, termed surfactant, was characterised in numerous biochemical studies of bronchoalveolar lavage (BAL) material and is now known to be composed of ≈90% (mass) lipids (with ≈80-90% phospholipids) and of ≈10% proteins. Its composition may deviate greatly in pathologic states (for review, see eg [7]). Unlike most other lipid-rich components of cells and organs, the surfactant lipids are characterised by an unusually high level of saturated fatty acid chains, such as the predominant dipalmitoylphosphatidylcholines, which contribute substantially to the unique properties of pulmonary surfactant (for review, see eg [8]).

7. Griese M: Pulmonary surfactant in health and human lung diseases: state of the art. Eur Respir J 1999, 13:1455–1476.

8. Van Golde LMG, Batenburg JJ, Robertson B: The pulmonary surfactant system. News in Physiol Sciences 1994, 9:13–20.

Anmerkungen

The source is not given. To be continued on the next page: Mag/Fragment_017_01

Sichter
(Hindemith) Schumann

Auch bei Fandom

Zufälliges Wiki